STADA, a leading international healthcare provider of high-quality generic medicine at an affordable price which has been in the global market for over 120 years has officially opened its doors to the Philippines yesterday, February 27, 2019, at the at the Fairmont Hotel in Makati City.
As medicine cost skyrockets nowadays, STADA’s sole goal is to alleviate the medical need of every Filipino by providing reduced healthcare cost and also widen doctors’ choices in prescribing better-quality medicine towards their patient.
“STADA Philippines aims to provide options for better health to all Filipinos,” Sharmaine Abarientos said the Commercial Director of STADA Philippines. “The patient as the center of what we do. We intend to back the barrier of cost with own quality generic products. With the purpose of improving compliance.”
She added that the patient’s journey inspires them at STADA to use the wealth of science, resources, and compassion to have a deeper understanding of every patient insights and what can be done, practically and realistically, for better health outcomes.
“We want to grow our business and also, we want to do as much as we can to improve health care in the Philippines,” told Gary Clark, STADA’s Asia Pacific Managing Director.
STADA not only take part by providing treatment for diseases but also promotes the overall well-being of every individual with their Out-of-the-counter drugs and nutraceuticals that are already been readily available in the market since July 2017. So far, the company already has nine registered products in the country.
“We are already here delivering products”, Clark said. “And now we are trying to exhilarate that process and introducing the product more quickly to the market and that’s one of the reasons why we are focusing on the over the counter medicines.
STADA’s OTC products are widely known in Europe and they have a very good manufacturing base in several European countries such as Germany, Serbia and some manufacturing sites outside Europe, particularly in Vietnam.
Hence, STADA’s aims to launch new products in the second quarter of the year. They also have a couple of products in development like combination products to be launched by 2020.
In the next two to three years, the company hopes to bring innovative cardiovascular products to the Philippines.
Meanwhile, STADA is also seeking to obtain partnerships with other pharmaceutical companies.
“STADA’s strategy is to expand, invest, and enter into partnerships to grow. By accelerating our efforts in seeking external partners to supplement our own local sales and marketing forces we can create transforming therapies and a sustained flow of commercial opportunities.” Abarientos added.
STADA Philippines, which has been at the forefront of championing the health and well-being of people around the world for the past 120 years.
With the vision of bringing affordable healthcare that meets international standards, it caters to the gaps in the growing health care market with emphasis on scientifically and clinically tested pharmaceutical products. The company also envisions itself to be the partner of choice for both generics and consumer health in Europe and selected emerging markets like the Philippines.
Originating in Germany, STADA is rooted in values and ethical practices which serve as its pillars in aiming for its strategic priorities.
STADA’s core values are: Integrity, making sure that all its practices are in line with the company’s internal as well as external standards; entrepreneurship, which encourages new ideas and actions creating future growth and value; and agility, which leads change with flexibility and decisiveness as part of their ongoing journey of personal development. These core values enjoin everyone to act in the best interests of the company and all its stakeholders, rather than their business unit or function.
Represented in about 50 sales companies in more than 30 countries, STADA Philippines is now ready to be an active partner in the local market, with its wide range of products to improve the health condition of Filipinos.
STADA branded products include Mar Plus and other OTC brands which are among the top sellers in their respective product category.
STADA also takes pride in offering cost-effective generic products. Prescription of these products offer cost savings which help make healthcare easy-on-the pocket, a goal which STADA has long been pushing for.
The quality of these generic products is ensured with strict quality control measures internally and by governmental regulatory authorities to guarantee their safety and efficacy.
As STADA Philippines makes it mark in the market, its ultimate goal is to be the partner of choice in generics, specialty and consumer health for all Filipinos.